- Report
- August 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- January 2025
- 183 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- March 2025
- 50 Pages
Global
From €2531EUR$2,650USD£2,116GBP
- Report
- March 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- March 2025
- 175 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4288EUR$4,490USD£3,586GBP
- Report
- September 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- May 2024
- 128 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- May 2024
- 129 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- May 2024
- 132 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- May 2024
- 139 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- May 2024
- 140 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1194EUR$1,250USD£998GBP
- Report
- September 2024
- 183 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- October 2018
- 30 Pages
China
From €2101EUR$2,200USD£1,757GBP
- Report
- April 2023
- 120 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- August 2024
- 80 Pages
Japan
From €3343EUR$3,500USD£2,795GBP
- Report
- February 2024
- 185 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- March 2023
- 130 Pages
Global
From €3438EUR$3,600USD£2,875GBP

Omeprazole is a proton pump inhibitor used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and erosive esophagitis. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Omeprazole works by blocking the enzyme in the stomach that produces acid, thus reducing the amount of acid in the stomach.
Omeprazole is available in both prescription and over-the-counter (OTC) forms. Prescription forms are typically used to treat more severe cases of GERD and other gastrointestinal disorders, while OTC forms are used to treat milder cases. Omeprazole is also available in combination with other medications, such as antibiotics, to treat more severe cases of GERD and other gastrointestinal disorders.
The market for Omeprazole is highly competitive, with many pharmaceutical companies offering their own versions of the drug. Some of the major players in the market include Pfizer, AstraZeneca, GlaxoSmithKline, Merck, and Novartis. Show Less Read more